Skip to main content

Find Clinical Trials

Home
Conditions
Blood-Borne Infections

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,277 public trials 443 recruiting studies

Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3

NCT01830127

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: 1241.30.10003 Boehringer Ingelheim Investigational Site La Mesa, California, United States

1241.30.10007 Boehringer Ingelheim Investigational Site San Diego, California, United States

1241.30.10001 Boehringer Ingelheim Investigational Site DeLand, Florida, United States

1241.30.10012 Boehringer Ingelheim Investigational Site West Palm Beach, Florida, United States

View all 19 locations

View Trial Details

Completed

Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations

NCT01517529

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: University of Cincinnati Cincinnati, Ohio, United States

View Trial Details

Completed

Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer

NCT00786422

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cardiovascular Diseases, +23 more
Locations: Redcliffe, Queensland, Australia

Vienna, State of Vienna, Austria

São Paulo, Brazil

München, Bavaria, Germany

View all 16 locations

View Trial Details

Completed

A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects

NCT00546715

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Advanced Clinical Research Institute Anaheim, California, United States

Orlando Clinical Research Center Orlando, Florida, United States

Parexel International Corporation Baltimore, Maryland, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection

NCT02166502

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada

The Hospital for Sick Children Toronto, Ontario, Canada

View Trial Details

Completed

Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV

NCT02606344

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +16 more
Locations: Sonal Foundation Mahesāna, Gujarat, India

Vinita Nursing Home Hindaun, Rajasthan, India

NMP Medical Research Institute Deharadun, Uttarakhand, India

View Trial Details

Completed

Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)

NCT00000142

Conditions: Blood-Borne Infections, CMV Cytomegalovirus Retinitis, Communicable Diseases, +21 more
Locations: Not specified

View Trial Details

Completed

Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)

NCT00000135

Conditions: Blood-Borne Infections, Communicable Diseases, Cytomegalovirus Infections, +20 more
Locations: Not specified

View Trial Details

Completed

Anal HPV Infection and Abnormal Cytology in HIV-infected Women

NCT00933140

Conditions: Blood-Borne Infections, Cervical Cancer Screening, Communicable Diseases, +12 more
Locations: Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

NCT00774397

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: 1220.5.0001 Boehringer Ingelheim Investigational Site San Francisco, California, United States

1220.5.0008 Boehringer Ingelheim Investigational Site San Francisco, California, United States

1220.5.0005 Boehringer Ingelheim Investigational Site Chicago, Illinois, United States

1220.5.0006 Boehringer Ingelheim Investigational Site Lutherville, Maryland, United States

View all 100 locations

View Trial Details